17-47253862-A-T

Variant summary

Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PVS1PM2

The NM_000212.3(ITGB3):​c.1A>T​(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000924 in 1,082,630 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 9.2e-7 ( 0 hom. )

Consequence

ITGB3
NM_000212.3 start_lost

Scores

5
1
9

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.875
Variant links:
Genes affected
ITGB3 (HGNC:6156): (integrin subunit beta 3) The ITGB3 protein product is the integrin beta chain beta 3. Integrins are integral cell-surface proteins composed of an alpha chain and a beta chain. A given chain may combine with multiple partners resulting in different integrins. Integrin beta 3 is found along with the alpha IIb chain in platelets. Integrins are known to participate in cell adhesion as well as cell-surface mediated signalling. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 10 ACMG points.

PVS1
Start lost variant, no new inframe start found.
PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ITGB3NM_000212.3 linkuse as main transcriptc.1A>T p.Met1? start_lost 1/15 ENST00000559488.7 NP_000203.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ITGB3ENST00000559488.7 linkuse as main transcriptc.1A>T p.Met1? start_lost 1/151 NM_000212.3 ENSP00000452786 P1P05106-1
ITGB3ENST00000571680.1 linkuse as main transcriptc.1A>T p.Met1? start_lost 1/91 ENSP00000461626
ITGB3ENST00000696963.1 linkuse as main transcriptc.1A>T p.Met1? start_lost 1/14 ENSP00000513002 P05106-2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
AF:
9.24e-7
AC:
1
AN:
1082630
Hom.:
0
Cov.:
30
AF XY:
0.00000194
AC XY:
1
AN XY:
515814
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000108
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpDec 27, 2023This sequence change affects the initiator methionine of the ITGB3 mRNA. The next in-frame methionine is located at codon 48. This variant is not present in population databases (gnomAD no frequency). Disruption of the initiator codon has been observed in individual(s) with Glanzmann thrombasthenia (PMID: 31029159). This variant disrupts a region of the ITGB3 protein in which other variant(s) (p.Cys39Gly) have been observed in individuals with ITGB3-related conditions (PMID: 16463284). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.47
D
BayesDel_noAF
Pathogenic
0.44
CADD
Benign
20
DANN
Benign
0.95
DEOGEN2
Benign
0.31
T;.
Eigen
Benign
-0.29
Eigen_PC
Benign
-0.21
FATHMM_MKL
Benign
0.31
N
LIST_S2
Uncertain
0.90
D;D
M_CAP
Pathogenic
0.91
D
MetaRNN
Pathogenic
0.99
D;D
MetaSVM
Benign
-0.90
T
MutationTaster
Benign
1.0
D;D;D
PROVEAN
Benign
-0.33
N;.
Sift
Pathogenic
0.0
D;.
Sift4G
Benign
0.41
T;T
Polyphen
0.0010
B;.
Vest4
0.81
MutPred
1.0
Gain of methylation at R6 (P = 0.1535);Gain of methylation at R6 (P = 0.1535);
MVP
0.94
ClinPred
1.0
D
GERP RS
3.3
Varity_R
0.95
gMVP
0.72

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr17-45331228; API